Thomas Felder

Thomas Felder is a Professor at the Paracelsus Medical Private University in Salzburg, Austria. He holds the position of European Registered Toxicologist and leads the Department of Medical-Chemical Laboratory Diagnostics. His research focuses on lipidomics, toxicology, and metabolic disorders with particular emphasis on liver diseases and cancer biology. He has authored over 118 publications, including high-impact studies on metabolite signatures in MASLD, epigenetic cancer risk assessment, and spinal cord injury recovery mechanisms.

• Roles: Chair of Toxicology, Principal Investigator in multiple funded projects
• Key Projects: Lipid droplet proteome regulation in NAFLD, lung lipidome analysis, plasma ceramide profiling
• Service: Editor-in-Chief of PTERIDINES, member of Antioxidants journal board, organizer of Winter-Workshops on Pteridine research

His work bridges clinical diagnostics with advanced analytical methods, developing LC-MS/MS protocols and in vitro toxicity workflows. Recent research highlights include discovering gut-liver crosstalk mechanisms in metabolic diseases and identifying surrogate tissue biomarkers for cancer prevention.